Immunotherapy for cervical and endometrial cancer: Latest data and future perspectives

9 Views

TAKE ACTION

Donations would go to support charities for #HEALTHCARE / Uterine Cancer

In #HEALTHCARE / Uterine Cancer

Prof Nicoletta Colombo speaks to ecancer at the BGICC 2020 conference in Cairo, Egypt about the recent data on the use of immunotherapy in cervical and endometrial cancers.

She states there are several phase II trials that have achieved a response rate of close to 50 percent in patients with MSI high tumours when treated with immune checkpoint inhibitors.

Prof Colombo believes this field is heading towards the use of combination approaches and describes some ongoing phase III trials that are investigating the combination of immune checkpoint inhibitors.

Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php

More ways to take action

Explore ways that you can help bring a solution to this issue.

Create Youms with
hashtags #HEALTHCARE

Create a challenge to
bring awareness to this issue for people to complete

Create a fundraiser to
support a charity that tackle this issue

Volunteer at charitable organization
that support this cause

Create a movement page dedicated to this cause to bring awareness.

Start a uCharity for this cause and invite people to join it to support this cause

Up next

Autoplay

Officials provide latest update on Eaton Fire raging in Pasadena

uchetex · 24 Views

Please note that if you are under 18, you won't be able to access this site. Please note that this site may contain sensitive material and viewers discretion is advised.

Up next

Immunotherapy for cervical and endometrial cancer: Latest data and future perspectives

Up next

Categories

Choose a payment method